10 March 2021

Assura

Assura is a real estate investment trust (REIT) that specialises in UK primary care medical centre real estate.

by Rheanna Filmer

Research Assistant

Group 10Created with Sketch.
Price
£0.75
Group 11Created with Sketch.
52 Week High-Low
£0.88—£0.62
Page 1Created with Sketch.
Net Yield
3.74%
Group 12Created with Sketch.
Hist / Pros Per
22.6—27.00
Page 1Created with Sketch.
Equity Market Cap
£2,019

The majority of their tenants are GPs, which accounts for c.70% of their income. The remaining income is generated 15% from other NHS tenants and 15% from peripheral medical services, like pharmacies. Assura’s income is “NHS backed” as GP’s rents are reimbursed by the NHS. Due to the specific structural needs of medical centres and a lack of supply of suitable buildings to meet these needs, Assura enjoys leases of 21+ years with very low default risk and sticky tenants that would struggle to leave their established customer base (i.e. their patients).

In April 2020, they raised £185m in equity to take advantage of attractive acquisition opportunities. Some of this capital was also deployed to their Asset Enhancement strategy to add extensions and more specific medical infrastructure to property already in their portfolio, for example a dedicated dementia centre. Assura’s relationship with the NHS provides secure income however this also means the NHS is an active participant in rent reviews and rents have to be deemed efficient for tax payers. Therefore, there is limited scope for rental growth, which is a challenge as they must then rely on acquisitions for significant growth.

Understanding Finance

Helping clients understand what we do is key to building relationships. To explain some of the industry jargon that creeps into our world, we’ve pulled together a section of our site to help.

Managing your wealth

Managing your wealth


Also in this issue

Today,  ASOS is best recognised as a leading online fashion retailer.

CyberArk shares are traded in America, although the company can trace its origins to the Israeli defence forces.

Terry Smith, founder and CEO of Fundsmith wrote in 2010 about the rationale for investing in Del Monte, which most people associated as a canned fruit producer.

Spring Issue Thirty Four